Market closed
The Joint Corp./JYNT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
Ticker
JYNT
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
619
Website
The Joint Corp. Metrics
BasicAdvanced
$168M
Market cap
-
P/E ratio
-$0.97
EPS
1.60
Beta
-
Dividend rate
Price and volume
Market cap
$168M
Beta
1.6
52-week high
$17.82
52-week low
$7.31
Average daily volume
47K
Financial strength
Current ratio
1.276
Quick ratio
0.618
Long term debt to equity
44.075
Total debt to equity
60.61
Interest coverage (TTM)
273.96%
Management effectiveness
Return on assets (TTM)
0.53%
Return on equity (TTM)
-49.10%
Valuation
Price to revenue (TTM)
1.382
Price to book
7.23
Price to tangible book (TTM)
14.75
Price to free cash flow (TTM)
27.222
Growth
Revenue change (TTM)
7.46%
Earnings per share change (TTM)
-526.86%
3-year revenue growth (CAGR)
19.58%
3-year earnings per share growth (CAGR)
-6.00%
What the Analysts think about The Joint Corp.
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for The Joint Corp. stock.
The Joint Corp. Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
The Joint Corp. Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
The Joint Corp. News
AllArticlesVideos
The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results
GlobeNewsWire·3 days ago
The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewsWire·2 weeks ago
The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for The Joint Corp. stock?
The Joint Corp. (JYNT) has a market cap of $168M as of October 26, 2024.
What is the P/E ratio for The Joint Corp. stock?
The price to earnings (P/E) ratio for The Joint Corp. (JYNT) stock is 0 as of October 26, 2024.
Does The Joint Corp. stock pay dividends?
No, The Joint Corp. (JYNT) stock does not pay dividends to its shareholders as of October 26, 2024.
When is the next The Joint Corp. dividend payment date?
The Joint Corp. (JYNT) stock does not pay dividends to its shareholders.
What is the beta indicator for The Joint Corp.?
The Joint Corp. (JYNT) has a beta rating of 1.6. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.